Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three US Ryan White Clinics.
Satisfaction and Treatment Burden Among Early Adopters of Long-Acting Injectable Cabotegravir-Rilpivirine With and Without Viremia in Three US Ryan White Clinics. Open Forum Infect Dis. 2026 Sep; 13(9):ofag559.
PMID: 42774744
The HIV dementia Champion Program: using implementation science to adapt and embed dementia training within an HIV context.
The HIV dementia Champion Program: using implementation science to adapt and embed dementia training within an HIV context. Aging Ment Health. 2026 Aug 20; 1-9.
PMID: 42625414
Distinct differences between COVID-19 vaccine refusers and vaccine hesitant in the United States: Results from a population-based survey and latent class analysis.
Distinct differences between COVID-19 vaccine refusers and vaccine hesitant in the United States: Results from a population-based survey and latent class analysis. Ann Epidemiol. 2026 Aug; 120:110118.
PMID: 42144042
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for HIV Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for HIV Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2026 Feb 25; 82(2):206-211.
PMID: 39873495
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United States.
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United States. J Int AIDS Soc. 2026 Feb; 29(2):e70082.
PMID: 41681062
Comparing Interest in Thigh Administration of Long-acting Cabotegravir/Rilpivirine Among Hypothetical Users, Early Adopters, and Trial Participants With Experience.
Comparing Interest in Thigh Administration of Long-acting Cabotegravir/Rilpivirine Among Hypothetical Users, Early Adopters, and Trial Participants With Experience. Clin Infect Dis. 2025 Dec 24; 81(5):e477-e479.
PMID: 40560533
What scientific inferences can be made with randomized implementation rollout trials.
What scientific inferences can be made with randomized implementation rollout trials. Implement Sci. 2025 12 11; 21(1):7.
PMID: 41382087
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic.
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic. J Antimicrob Chemother. 2025 11 04; 80(11):3092-3100.
PMID: 40981754
Socioenvironmental and mental health determinants of alcohol use among Black sexually minoritized men and transgender women: Findings from the N2 cohort study.
Socioenvironmental and mental health determinants of alcohol use among Black sexually minoritized men and transgender women: Findings from the N2 cohort study. J Gay Lesbian Ment Health. 2025 Sep 18.
PMID: 40995042
Understanding Opportunities for Prescribing Pre-exposure Prophylaxis at Two Academic Medical Centers in a High Priority Jurisdiction for Ending the HIV Epidemic.
Understanding Opportunities for Prescribing Pre-exposure Prophylaxis at Two Academic Medical Centers in a High Priority Jurisdiction for Ending the HIV Epidemic. AIDS Behav. 2025 Oct; 29(10):3162-3171.
PMID: 40490656